Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 
Online Report Subscribers, Click Here
Pricing and Ordering Information
ClearState

China Market for Interventional Cardiology Products
Report #CS201CH - December 2009

Cardiovascular disease is the leading cause of death in China and has become a major epidemic, killing an estimated 2.6 million people annually and continues to grow at a rapid rate of 25% annually. Cardiologists and patients across China are increasingly likely to opt for interventional procedures to treat cardiovascular diseases due to their less invasive nature, the higher risk of stroke in open-heart surgery, and “benefits” in the form of “rebates” given by suppliers to clinicians from the usage of interventional cardiology medical devices. Established interventional cardiology procedures (diagnostic angiography, PTCA and coronary stenting, among others) are performed widely in China, largely in Level 3 hospitals equipped with catheterization laboratories. The more advanced procedures and devices are typically concentrated at large cardiology specialized Level 3A hospitals in key metropolitan areas and major cities.

The overall interventional cardiology products market in China will experience strong growth from approximately $770 million in 2008 to an estimated $1.8 billion in 2012, an estimated compound annual growth rate of 23%. Key demand drivers include a surge in disease incidence due to affluence and lifestyle changes, a resulting increase in demand for diagnosis and treatment, and price cuts due to increasing competition from domestic suppliers and government price reduction initiatives, among other factors. The main constraints to growth remain high device and procedure costs for the average population, inadequate insurance coverage, a limited number of clinicians and uneven skill levels across hospitals. In terms of market share, the supplier landscape has undergone considerable change in the high value medical device segments. In particular, domestic Chinese suppliers, with their lower cost positioning, have made great inroads manufacturing coronary stenting and transcatheter septal defect repair devices to the extent of achieving market dominance.

This market intelligence report analyzes the following diagnostic and therapeutic interventional cardiology procedures and associated product groups: coronary angiography; intravascular ultrasound (IVUS); balloon valvuloplasty; chronic total occlusion (CTO) crossing; embolic protection; mechanical atherectomy; percutaneous transluminal coronary angioplasty and stenting; thrombectomy; transcatheter septal defect repair; and vascular puncture closure (VPC).

Ordering Information

Title

 Report# Publication
Date		 List Price

China Market for Interventional Cardiology Products

CS201CH

December 2009

$5,950
Order Online:
Single User only (Please call for corporate subscription pricing)		     PDF Only

Save $100 off the regular print only price when you order online.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

1. EXECUTIVE SUMMARY

1.1 Interventional cardiology procedures and devices

1.2 Interventional cardiology products market

1.3 Methodology

 

2. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES AND DISORDERS

2.1 Cardiovascular system: structure and function

2.2 Vascular diseases and disorders

2.2.1 Atherosclerosis

2.2.2 Coronary heart disease

2.2.2.1 Angina pectoris

2.2.2.2 Myocardial infarction

2.3 Myocardial diseases and disorders

2.3.1 Congestive heart failure

2.3.2 Rheumatic fever / Rheumatic heart disease

2.3.3 Heart valve disorders

2.3.4 Congenital cardiovascular defects

 

3. INTERVENTIONAL CARDIOLOGY PROCEDURES

3.1 Diagnostic procedures

3.1.1 Coronary angiography

3.1.1.1 Indications

3.1.1.2 Procedure volumes

3.1.2 Intravascular ultrasound

3.1.2.1 Indications

3.1.2.2 Procedure volumes

3.2 Therapeutic procedures

3.2.1 Percutaneous Transluminal Coronary Angioplasty

3.2.1.1 Indications

3.2.1.2 Procedure volumes

3.2.2 Coronary stenting

3.2.2.1 Indications

3.2.2.2 Types of stents

3.2.2.3 Procedure volumes

3.2.3 Mechanical thrombectomy

3.2.3.1 Indications

3.2.3.2 Procedure volumes

3.2.4 Chronic total occlusion crossing

3.2.4.1 Indications

3.2.4.2 Procedure volumes

3.2.5 Embolic protection

3.2.5.1 Indications

3.2.5.2 Procedure volumes

3.2.6 Percutaneous Balloon Valvuloplasty

3.2.6.1 Indications

3.2.6.2 Procedure volumes

3.2.7 Transcatheter septal defect repair

3.2.7.1 Indications

3.2.7.2 Procedure volumes

3.2.8 Vascular access site closure

3.2.8.1 Indications

3.2.8.2 Procedure volumes

 

4. INTERVENTIONAL CARDIOLOGY PRODUCTS MARKET

4.1 Diagnostic interventional cardiology products

4.1.1 Coronary angiography devices

4.1.1.1 Device types and available products

4.1.1.2 Market size and forecast

4.1.2 Intravascular ultrasound devices

4.1.2.1 Device types and available products

4.1.2.2 Market size and forecast

4.2 Therapeutic interventional cardiology products

4.2.1 Percutaneous transluminal coronary angioplasty devices

4.2.1.1 Device types and available products

4.2.1.2 Market size and forecast

4.2.2 Coronary stenting devices

4.2.2.1 Device types and available products

4.2.2.2 Market size and forecast

4.2.3 Mechanical thrombectomy devices

4.2.3.1 Device types and available products

4.2.3.2 Market size and forecast

4.2.4 Chronic total occlusion crossing devices

4.2.4.1 Device types and available products

4.2.4.2 Market size and forecast

4.2.5 Embolic protection devices

4.2.5.1 Device types and available products

4.2.5.2 Market size and forecast

4.2.6 Percutaneous balloon valvuloplasty devices

4.2.6.1 Device types and available products

4.2.6.2 Market size and forecast

4.2.7 Transcatheter septal defect repair devices

4.2.7.1 Device types and available products

4.2.7.2 Market size and forecast

4.2.8 Vascular access site closure devices

4.2.8.1 Device types and available products

4.2.8.2 Market size and forecast

 

5. INTERVENTIONAL CARDIOLOGY PRODUCTS SUPPLIERS

5.1 Coronary angiography

5.2 Percutaneous transluminal coronary angioplasty devices

5.3 Coronary stenting

5.4 Transcatheter septal defect repair devices

 

6. COMPANY PROFILES

6.1 Cordis / Johnson & Johnson

6.2 Abbott Vascular

6.3 Boston Scientific

6.4 Medtronic, Inc.

6.5 Terumo Medical

6.6 MicroPorts Medical

6.7 Lepu Medical

6.8 JW Medical

 

7. HOSPITAL PROFILES

7.1. Fuwai Hospital & Cardiovascular Institute

7.2 Beijing Anzhen Hospital

7.3 Fudan University Zhongshan Hospital

7.4 Guangdong Provincial People’s Hospital

7.5 Wuhan Union Hospital

7.6 Ruijin Hospital

 

TABLE OF EXHIBITS

Exhibit 1-1:      Interventional Cardiology Procedure and Device Map

Exhibit 1-2:      Diagnostic and Therapeutic Interventional Cardiology, Procedure Volumes Forecast, 2008–2012

Exhibit 1-3:      Diagnostic and Therapeutic Interventional Cardiology Products Sales, Market Forecast, 2008–2012

Exhibit 1-4:      Diagnostic Interventional Cardiology, Procedure Volumes Forecast, 2008–2012

Exhibit 1-5:      Diagnostic Interventional Cardiology Products Sales, Market Forecast, 2008–2012

Exhibit 1-6:      Therapeutic Interventional Cardiology, Procedure Volumes Forecast, 2008–2012

Exhibit 1-7:      Therapeutic Interventional Cardiology Products Sales, Market Forecast, 2008–2012

Exhibit 1-8:      2008, Coronary Angiography Devices Market, Share by Supplier

Exhibit 1-9:      2008, Percutaneous Transluminal Coronary Angioplasty Products Market, Share by Supplier

Exhibit 1-10:    2008, Coronary Stenting Products Market, Share by Supplier

Exhibit 1-11: 2008,      Transcatheter Septal Defect Repair Products Market, Share by Supplier

 

Exhibit 2-1:      Standard Angina Pectoris Classification

Exhibit 2-2:      New York Heart Association Classification System for Congestive Heart Failure

 

Exhibit 3-1:      Coronary Angiography, Procedure Volumes Forecast, 2008–2012

Exhibit 3-2:      ACC / AHA Guidelines for coronary IVUS indications for use

Exhibit 3-3:      Intravascular Ultrasound, Procedure Volumes Forecast, 2008–2012

Exhibit 3-4:      Percutaneous Transluminal Coronary Angioplasty, Caseload Forecast, 2008–2012

Exhibit 3‑5:      Coronary Stenting, Caseload Forecast, 2008–2012

Exhibit 3‑6:      Coronary Mechanical Thrombectomy, Caseload Forecast, 2008–2012

Exhibit 3‑7:      Chronic Total Occlusion Crossing, Procedure Volumes, 2008–2012

Exhibit 3‑8:      Embolic Protection in Patients Undergoing Percutaneous Coronary Interventions and Saphenous Vein Grafting, Procedure Volumes, 2008–2012

Exhibit 3‑9:      Percutaneous Balloon Valvulopasty, Procedure Volumes, 2008–2012

Exhibit 3‑10:    Transcatheter Septal Defect Repair, Procedure Volumes, 2008–2012

Exhibit 3‑11:    Vascular Access Site Closure, Procedure Volumes, 2008–2012

 

Exhibit 4-1:      Interventional Cardiology Procedure and Device Map

Exhibit 4-2:      Diagnostic and Therapeutic Interventional Cardiology, Procedure Volumes Forecast, 2008–2012

Exhibit 4-3:      Diagnostic and Therapeutic Interventional Cardiology Products Sales, Market Forecast, 2008–2012

Exhibit 4-4:      Coronary Angiography Device Overview

Exhibit 4-5:      Selected Coronary Angiography Catheters

Exhibit 4-6:      Coronary Angiography Devices, Market Forecast, 2008–2012

Exhibit 4-7:      Selected Coronary Intravascular Ultrasound Catheter Products

Exhibit 4-8:      Coronary Angiography Devices Market Forecast, 2008–2012

Exhibit 4-9:      Therapeutic Interventional Cardiology, Procedure Volumes Forecast, 2008–2012

Exhibit 4-10:    Therapeutic Interventional Cardiology Products Sales, Market Forecast, 2008–2012

Exhibit 4-11:    Coronary Angioplasty Device Overview

Exhibit 4-12:    Selected Percutaneous Transluminal Coronary Angioplasty Balloon Catheters

Exhibit 4-13:    Selected Coronary Guiding Catheters

Exhibit 4-14:    Selected Coronary Guidewires for Therapeutic Procedures

Exhibit 4-15:    Selected Introducers / Sheaths

Exhibit 4-16:    Selected Inflation Devices

Exhibit 4-17:    Percutaneous Transluminal Coronary Angioplasty Devices Market Forecast, 2008–2012

Exhibit 4-8:      Selected Coronary Stents / Stenting Systems

Exhibit 4-19:    Coronary Stents / Stenting Systems Market Forecast, 2008–2012

Exhibit 4-20:    Coronary Mechanical Thrombectomy Devices, 2008–2012

Exhibit 4-21:    Selected Chronic Total Occlusion Crossing Systems

Exhibit 4-22:    Coronary Mechanical Chronic Total Occlusion Crossing Systems, 2008–2012

Exhibit 4-23:    Selected Coronary Embolic Protection Systems

Exhibit 4-24:    Coronary Embolic Protection Systems, 2008–2012

Exhibit 4-25:    Selected Percutaneous Balloon Valvuloplasty Systems

Exhibit 4-26:    Percutaneous Balloon Valvuloplasty Systems, 2008–2012

Exhibit 4-27:    Selected Transcatheter Septal Defect Repair Systems

Exhibit 4-28:    Transcatheter Septal Defect Repair Devices, 2008–2012

Exhibit 4-29:    Selected Vascular Access Site Closure Systems

Exhibit 4-30:    Vascular Access Site Closure Systems, 2008–2012

 

Exhibit 5-1:      2008, Coronary Angiography Devices Market, Share by Supplier

Exhibit 5-2:      2008, Percutaneous Transluminal Coronary Angioplasty Products Market, Share by Supplier

Exhibit 5-3:      2008, Coronary Stenting Products Market, Share by Supplier

Exhibit 5-5:      2008, Transcatheter Septal Defect Repair Products Market, Share by Supplier

Clearstate is a market intelligence firm offering customized strategic advisory and primary research solutions specifically addressing the Healthcare and Life Sciences domains within the Asia Pacific region. www.clearstate.com

*The pdf version of each report costs an additional $750 when purchased in addition to the hardcopy.

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact sales@medtechinsight.com. From outside the U.S., contact internationalsales@medtechinsight.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home